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JWH-184	 -9.268	 -67.039	 23	nM	
JWH-164	 -9.178	 -68.191	 6.6nM	±	0.7		
JWH-007	 -9.088	 -68.246	 9.5nM	±	4.5		
JWH-015	 -9.044	 -60.755	 383	nM	
JWH-122	 -8.895	 -64.202	 0.69	nM	±	0.5	
JWH-120	 -8.872	 -61.182	 1054	nM	
JWH-098	 -8.845	 -40.368	 4.5	nM	±	0.1	
JWH-081	 -8.84	 -63.183	 1.2	nM	±	0.03	
JWH-196	 -8.784	 -62.894	 151	nM	±	18	
JWH-148	 -8.756	 -64.212	 123	nM	
JWH-424	 -8.725	 -56.65	 20.9	nM	
JWH-073	 -8.706	 -61.424	 8.9	nM	
THC	
Molecule		 -8.686	 -63.34	 10	nM	
JWH-019	 -8.595	 -42.71	 9.8	nM	±	2	
JWH-210	 -8.536	 -54.984	 .46	nM	
JWH-116	 -8.5	 -54.951	 52	nM	±	5.0		
JWH-018	 -8.424	 -58.632	 9	nM	±	5.0	
JWH-185	 -8.074	 -68.61	 17	nM	
JWH-047	 -7.559	 -56.017	 59	nM	±	3.0	
JWH-398	 -7.452	 -61.263	 2.3	nM	
JWH-048	 -7.198	 -36.605	 10.7	nM	±	1.0	
Table	1:	Docking	Score	and	Glide	Emodel	score	of	each	JWH	ligand	and	THC		 		 Figure	4	and	Figure	24	show	the	two	ligands	and	their	interactions	with	the	CB1	model	that	had	the	best	docking	score	and	the	lowest	docking	score,	respectively.	JWH-149	was	shown	to	have	the	most	favorable	docking	score	of	-9.334,	and	JWH-	048	was	shown	to	have	the	least	favorable	docking	score	of	-7.198.	Figure	4	and	table	3	show	that	JWH-	149	has	Π-Π	stacking	interactions	with	residues	Tryptophan	279	(Trp	279),	Tryptophan	356	(Trp	356),	Phenylalanine	170	(Phe	170),	and	Phenylalanine	200	(Phe	200).	Most	ligands	that	resulted	in	high	
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docking	scores	showed	primarily	the	following	interactions	with	the	CB1	protein:	indole	substituent	interactions	with	Trp	279	and	to	a	lesser	degree	with	Phe	170	and	Trp	356;	naphthalene	interactions	with	Phe	170,	Trp	356,	and	Phe	200.			 		 Previous	studies	have	shown	that	residues	Serine	383	(Ser	383)	and	Lys	192	are	key	residues	in	forming	hydrogen	bonds	with	cannabinoid	ligands	possessing	OH	and	COOH	groups,	respectively.10	The	results	of	this	study	showed	that	only	two	docked	ligands	had	an	interaction	with	Lys	192.	A	hydrogen	bond	was	formed	between	Lys	192	and	the	keto-oxygen	portion	of	ligand	JWH-073,	and	Lys	192	had	a	pi-	cation	interaction	with	the	naphthalene	portion	of	ligand	JWH-048.	Interestingly,	JWH-073	had	a	docking	score	of	-8.706,	and	JWH-048	as	stated	previously	had	the	lowest	docking	score	of	-7.198.	Ser	383	also	formed	a	hydrogen	bond	with	the	keto-oxygen	of	ligands	JWH-098	and	JWH-424.	The	docking	scores	of	these	two	ligands	were	-8.845	and	-8.725,	respectively.	Analysis	of	the	interactions	between	the	CB1	model	and	the	ligands	also	showed	that	another	residue	formed	a	hydrogen	bond	in	the	same	way	with	the	keto-oxygen	of	the	ligands.	Similar	to	Lys	192	and	Ser	383,	Trp	279	formed	a	hydrogen	bond	with	the	keto-oxygen	of	ligands	JWH-015,	JWH-019,	JWH-018,	and	JWH-047.	The	docking	scores	of	each	of	these	ligands	were	-9.044,	-8.595,	-8.424,	and	-7.559,	respectively.				 The	strength	of	each	hydrogen	bond	formed	and	cation-pi	interaction	was	analyzed	through	measuring	the	distance	in	Angstroms.	The	hydrogen	bond	distance	between	Lys	192	and	JWH-073	was	measured	to	be	2.40Å	and	the	cation-pi	
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interaction	distance	between	Lys	192	and	JWH-	048	was	measured	to	be	3.77Å.	The	hydrogen	bond	distances	between	Trp	279	and	JWH-	015,	JWH-	019,	JWH-	018,	and	JWH-	047	were	measured	to	be	2.17	Å,	1.90	Å,	2.43	Å,	and	2.23	Å,	respectively.		The	hydrogen	bond	distance	between	Ser	383	and	JWH-	098	was	1.98	Å,	and	the	hydrogen	bond	distance	between	Ser	383	and	JWH-	424	was	2.04	Å.	The	shorter	distance	indicates	the	stronger	interaction.	The	distance	and	strength	of	each	hydrogen	bond	can	be	seen	in	table	2.			
Ligands		 Lys	192	 Trp	279	 Ser	383	
JWH-	073	 2.4	Å	 		 		
JWH-	015	 		 2.17	Å	 		
JWH-	019	 		 1.9	Å	 		
JWH-	018	 		 2.43	Å	 		
JWH-	047	 		 2.23	Å	 		
JWH-	098	 		 		 1.98	Å	










	 	 	Ligands		 Trp	279	 Trp	356	 Phe	170	 Phe	200	 Phe	177	 Phe	174	 Lys	192	 Ser	383	
THC	
Molecule	 ✓    	 	 	 	
JWH-149	 ✓ ✓ ✓ ✓ 		 		 		 		
JWH-184	 ✓ ✓ ✓ 		 		 		 		 		
JWH-073	 ✓ 		 		 		 		 		 ✓ 		
JWH-164	 ✓ ✓ 		 ✓ 		 		 		 		
JWH-007	 ✓ ✓ 		 ✓ 		 		 		 		
JWH-015	 ✓ ✓ ✓ 		 		 		 		 		
JWH-122	 ✓ ✓ ✓ 		 		 		 		 		
JWH-120	 ✓ ✓ 		 ✓ 		 		 		 		
JWH-098	 ✓ ✓ 		 ✓ 		 		 		 ✓ 
JWH-081	 ✓ ✓ ✓ ✓ 		 		 		 		
JWH-196	 ✓ ✓ 		 ✓ 		 		 		 		
JWH-148	 ✓ 		 		 		 		 		 		 		
JWH-424	 ✓ ✓ ✓ ✓ 		 		 		 ✓ 
JWH-019	 ✓ 		 		 		 		 		 		 		
JWH-210	 		 ✓ ✓ 		 		 		 		 		
JWH-116	 		 ✓ ✓ ✓ 		 		 		 		
JWH-018	 ✓ ✓ ✓ 		 		 		 		 		
JWH-185	 ✓ ✓ ✓ 		 		 		 		 		
JWH-047	 ✓ 		 ✓ ✓ 		 		 		 		
JWH-398	 		 		 		 		 		 		 		 		
JWH-048	 ✓ 		 		 		 ✓ ✓ ✓ 		
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